← Back to Search

Online Yoga vs. Behavioral Therapy for Depression

N/A
Recruiting
Led By Louisa Sylvia, PhD
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week: 0, 6, 12, 18, 24
Awards & highlights
No Placebo-Only Group

Summary

This trial compares online group yoga classes and one-on-one online therapy sessions for adults with significant depression. Yoga reduces stress and promotes relaxation, while therapy encourages activities that improve mood. Yoga has been explored as a complementary treatment for depression and anxiety, showing potential benefits in enhancing engagement and perceived clinical outcomes.

Who is the study for?
Adults with depression (PHQ-9 score ≥10) who can read English or Spanish, live in NC, MA, MN, or RI and have a healthcare provider. Not for those with recent bone fractures/joint surgery, severe heart/lung disease, advised against exercise by a doctor, currently pregnant or engaged in yoga/psychotherapy recently.
What is being tested?
This study compares an online group-based yoga program to individualized behavioral therapy (BA) for depression over 12 weeks. Participants will be randomly assigned to either the yoga or BA group and assessed at multiple points during and after treatment.
What are the potential side effects?
Potential side effects are not specified but may include typical risks associated with physical activity like muscle strain for the yoga intervention. Behavioral Activation Therapy generally has minimal side effects but could include emotional discomfort.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week: 0, 6, 12, 18, 24
This trial's timeline: 3 weeks for screening, Varies for treatment, and week: 0, 6, 12, 18, 24 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Patient Health Questionnaire-9 (PHQ-9)
Secondary study objectives
PROMIS-29 Anxiety Subscale
PROMIS-29 Sleep Subscale
World Health Organization-5 Well-Being Index (WHO-5)
Other study objectives
PROMIS Anger
PROMIS-29 Pain Interference
PROMIS-29 Physical Functioning Subscale
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Active Control
Group I: Behavioral ActivationActive Control1 Intervention
The goal of Behavioral Activation Psychotherapy is to help people identify and (re)engage in meaningful and positive activities through psychoeducation, identification of values and associated activities, goal setting, problem-solving, and monitoring of goal completion. There will be a BA manual for therapists and training provided by study staff on the manual (e.g., asynchronous and synchronous training sessions). BA therapists will be community clinicians. BA will be provided individually via telehealth and will be billed to participant insurance. At the start of BA treatment, participants will be oriented to the time-limited nature of BA, with the expectation that they will attend 8 sessions over the course of 3 months.
Group II: Yoga-based InterventionActive Control1 Intervention
Yoga classes will be gentle and physically accessible for people who are naïve to yoga. Teachers will frequently guide participants to focus on their breathing and coordinate movements with breath. Teachers will offer variations on the postures and encourage participants to choose variations that provide some challenge but do not cause strain or pain. Classes will be 1 hour long and include a brief sitting meditation, warm-ups, standing postures, and a final resting meditation. All participants will be invited to attend a synchronous yoga class via a HIPAA-compliant videoconference option once per week during the first 3 months of the study. Classes will be offered at multiple times throughout the week.

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for depression, such as yoga and behavioral therapies, work through several mechanisms. Yoga and similar practices reduce stress by lowering cortisol levels and promoting relaxation, which can alleviate symptoms of anxiety and depression. These activities also improve mood by increasing the production of endorphins and serotonin, neurotransmitters associated with feelings of well-being and happiness. Additionally, the physical activity involved in yoga enhances overall physical health, which can lead to better mental health outcomes. For depression patients, these mechanisms are crucial as they address both the psychological and physiological aspects of the disorder, providing a holistic approach to treatment.

Find a Location

Who is running the clinical trial?

Butler HospitalOTHER
131 Previous Clinical Trials
15,990 Total Patients Enrolled
31 Trials studying Depression
5,871 Patients Enrolled for Depression
Brown UniversityOTHER
466 Previous Clinical Trials
698,463 Total Patients Enrolled
30 Trials studying Depression
11,224 Patients Enrolled for Depression
Massachusetts General HospitalLead Sponsor
3,026 Previous Clinical Trials
13,413,362 Total Patients Enrolled
192 Trials studying Depression
33,544 Patients Enrolled for Depression
Hennepin Healthcare Research InstituteOTHER
92 Previous Clinical Trials
76,675 Total Patients Enrolled
2 Trials studying Depression
19,122 Patients Enrolled for Depression
Wake Forest University Health SciencesOTHER
1,401 Previous Clinical Trials
2,459,811 Total Patients Enrolled
38 Trials studying Depression
35,508 Patients Enrolled for Depression
Medical University of South CarolinaOTHER
978 Previous Clinical Trials
7,400,411 Total Patients Enrolled
43 Trials studying Depression
6,820 Patients Enrolled for Depression
Louisa Sylvia, PhDPrincipal InvestigatorMassachusetts General Hospital
2 Previous Clinical Trials
60 Total Patients Enrolled
1 Trials studying Depression
24 Patients Enrolled for Depression
Lisa Uebelacker, PhDPrincipal InvestigatorButler Hospital
9 Previous Clinical Trials
650 Total Patients Enrolled
5 Trials studying Depression
351 Patients Enrolled for Depression

Media Library

Online- BA Clinical Trial Eligibility Overview. Trial Name: NCT05546697 — N/A
Depression Research Study Groups: Behavioral Activation, Yoga-based Intervention
Depression Clinical Trial 2023: Online- BA Highlights & Side Effects. Trial Name: NCT05546697 — N/A
Online- BA 2023 Treatment Timeline for Medical Study. Trial Name: NCT05546697 — N/A
Depression Patient Testimony for trial: Trial Name: NCT05546697 — N/A
~218 spots leftby May 2026